U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H25N3O
Molecular Weight 323.432
Optical Activity ( + )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYSERGIDE

SMILES

[H][C@@]12CC3=CNC4=C3C(=CC=C4)C1=C[C@H](CN2C)C(=O)N(CC)CC

InChI

InChIKey=VAYOSLLFUXYJDT-RDTXWAMCSA-N
InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1

HIDE SMILES / InChI
Molecular Formula C20H25N3O
Molecular Weight 323.432
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:21:01 UTC 2023
Edited
by admin
on Sat Dec 16 16:21:01 UTC 2023
Record UNII
8NA5SWF92O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LYSERGIDE
HSDB   INN   MI   WHO-DD  
INN  
Official Name English
(+)-LYSERGIC ACID DIETHYLAMIDE
Common Name English
9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-ERGOLINE-8B-CARBOXAMIDE
Common Name English
LSD-25
Common Name English
DEXTROLYSERGIC ACID DIETHYLAMIDE
Common Name English
(8.BETA.)-9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYLERGOLINE-8-CARBOXAMIDE
Systematic Name English
ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-, (5.BETA., 8.BETA.)-
Common Name English
N,N-DIETHYLLYSERGAMIDE
Common Name English
lysergide [INN]
Common Name English
LYSERGIDE [MI]
Common Name English
LYSERGIDE [HSDB]
Common Name English
LYSERGIC ACID DIETHYLAMIDE
Common Name English
Lysergide [WHO-DD]
Common Name English
(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Systematic Name English
LSD
Code English
(+)-LYSERGIDE (INCB:GREEN LIST)
Common Name English
D-LSD
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
CFR 21 CFR 862.3580
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
NCI_THESAURUS C47794
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
WIKIPEDIA TiHKAL
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
DEA NO. 7315
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
Code System Code Type Description
DRUG CENTRAL
1621
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
HSDB
3920
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
CAS
50-37-3
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
INN
729
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
MERCK INDEX
m6965
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY Merck Index
CHEBI
6605
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
WIKIPEDIA
LYSERGIC ACID DIETHYLAMIDE
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
INCB IDS CODE
PL 002
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
EPA CompTox
DTXSID1023231
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
ChEMBL
CHEMBL263881
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-033-2
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
EVMPD
SUB08628MIG
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
DRUG BANK
DB04829
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
NCI_THESAURUS
C76104
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
FDA UNII
8NA5SWF92O
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
PUBCHEM
5761
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
MESH
D008238
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
SMS_ID
100000081735
Created by admin on Sat Dec 16 16:21:04 UTC 2023 , Edited by admin on Sat Dec 16 16:21:04 UTC 2023
PRIMARY
Related Record Type Details
5-HYDROXYTRYPTAMINE RECEPTOR 7
TARGET -> AGONIST
Ki
D(1A) DOPAMINE RECEPTOR
OFF TARGET->LIGAND
BINDING
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 1D
TARGET -> AGONIST
Ki
Structure of ERGONOVINE
PRECURSOR->PARENT
Structure of BU-LAD
DERIVATIVE -> PARENT
D(4) DOPAMINE RECEPTOR
OFF TARGET->LIGAND
BINDING
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 1A
TARGET -> AGONIST
Ki
Structure of ERGOCRISTINE
PRECURSOR->PARENT
Structure of LYSERGIDE D-TARTRATE
SALT/SOLVATE -> PARENT
5-HYDROXYTRYPTAMINE RECEPTOR 2A
TARGET -> AGONIST
[3H]ketanserin radioligand
Ki
Structure of LYSERGIDE TARTRATE
SALT/SOLVATE -> PARENT
5-HYDROXYTRYPTAMINE RECEPTOR 5A
TARGET -> AGONIST
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 2C
TARGET -> AGONIST
Ki
D(2) DOPAMINE RECEPTOR
OFF TARGET->LIGAND
BINDING
Ki
D(1B) DOPAMINE RECEPTOR
OFF TARGET->LIGAND
BINDING
Ki
Structure of DIETHYLAMINE
PRECURSOR->PARENT
D(3) DOPAMINE RECEPTOR
OFF TARGET->LIGAND
BINDING
Ki
Structure of LYSERGIC ACID DIETHYLAMIDE HYDROBROMIDE
SALT/SOLVATE -> PARENT
5-HYDROXYTRYPTAMINE RECEPTOR 6
TARGET -> AGONIST
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 2A
TARGET -> AGONIST
[125I]DOI was the radioligand.
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 1E
TARGET -> AGONIST
Ki
5-HYDROXYTRYPTAMINE RECEPTOR 2B
TARGET -> AGONIST
Ki
Structure of LYSERGIDE MALEATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of 1-PROPIONYL-LYSERGIC ACID DIETHYLAMIDE
PRODRUG -> METABOLITE ACTIVE
A recent intoxication case involving 1P-LSD indicated formation of LSD in vivo with no detection of the parent molecule.
Structure of 1B-LSD
PRODRUG -> METABOLITE ACTIVE
Structure of 1V-LSD
PRODRUG -> METABOLITE ACTIVE
Structure of 2-OXO-3-HYDROXY-LYSERGIDE
METABOLITE -> PARENT
URINE
Structure of ALD-52
PRODRUG -> METABOLITE ACTIVE
High levels of LSD were detected in the plasma of rats after subcutaneous administration of ALD-52 and 1P-LSD, demonstrating these compounds are rapidly and efficiently deacylated in vivo.
Structure of 2,3-DIHYDROXY LYSERGIC ACID DIETHYLAMIDE
METABOLITE -> PARENT
Related Record Type Details
Structure of LYSERGIDE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966